uz
Feedback
Introduction Modules | MW

Introduction Modules | MW

Kanalga Telegram’da o‘tish

Data Introduction Modules لمشاركة القناة - https://t.me/Introduction_Modules البوت - https://t.me/Introduction_ModulesBot القناة الرئيسية - @Medicine_Way2

Ko'proq ko'rsatish

📈 Telegram kanali Introduction Modules | MW analitikasi

Introduction Modules | MW (@introduction_modules) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 26 033 obunachidan iborat bo'lib, Tibbiyot toifasida 818-o'rinni va Misr mintaqasida 723-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 26 033 obunachiga ega bo‘ldi.

11 Iyun, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 58 ga, so‘nggi 24 soatda esa -3 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 3.64% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining N/A% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 0 marta ko‘riladi; birinchi sutkada odatda 0 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 0 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent module, general, microbiology, summary, بارا kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
Data Introduction Modules لمشاركة القناة - https://t.me/Introduction_Modules البوت - https://t.me/Introduction_ModulesBot القناة الرئيسية - @Medicine_Way2

Yuqori yangilanish chastotasi (oxirgi ma’lumot 12 Iyun, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

26 033
Obunachilar
-324 soatlar
+127 kunlar
+5830 kunlar
Postlar arxiv
28 - Non-selective adrenergic blockers.mp4 Quality : 🎬 480p

27 - ANS- Beta blocker 3.mp4 Quality : 🎬 480p

26 - ANS- Beta blockers 1.mp4 Quality : 🎬 480p

25 - ANS- Beta blockers 2.mp4 Quality : 🎬 480p

24 - ANS: Noradrenaline and dopamine.mp4 Quality : 🎬 480p

23 - ANS: Hyoscine, Atropine substitutes, Ganglion blocker and stimulants.mp4 Quality : 🎬 480p

22 - ANS: Synthetic sympathomimetics.mp4 Quality : 🎬 480p

21 - ANS: Adrenaline.mp4 Quality : 🎬 480p

20 - ANS: Sympathetic nervous system.mp4 Quality : 🎬 480p

19 - ANS: Atropine.mp4 Quality : 🎬 480p

18 - ANS: Parasympathomimetic drugs.mp4 Quality : 🎬 480p

17 - ANS: Intro.mp4 Quality : 🎬 480p

16 - ANS: Parasympathetic nervous system.mp4 Quality : 🎬 480p

15 - Pediatrics pharmacology.mp4 Quality : 🎬 480p

14 - OTC and drug development.mp4 Quality : 🎬 480p

13 - Pharmacodynamics: Adverse effects.mp4 Quality : 🎬 480p

12 - Pharmacodynamics: Drug drug interaction.mp4 Quality : 🎬 480p

11 - Geriatric pharmacology.mp4 Quality : 🎬 480p

10 - Pharmacodynamics: Idiosyncrasy.mp4 Quality : 🎬 480p

9 - Pharmacodynamics: Mechanism of action.mp4 Quality : 🎬 480p